We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“What we're now saying is that a physician who chooses a conservative strategy is not a pariah. It's an acceptable strategy, except for unstable patients.”
“We at AstraZeneca are very pleased with the latest development with the AHA/ACC guideline recognizing ticagrelor as the preferred drug over the current standard of care in the treatment of NSTE-ACS patients undergoing a broad range of treatment strategies.”
No takes yet. Share an insight, caveat, or question.
Amsterdam et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: